InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.155
+0.005 (0.43%)
Jan 6, 2026, 1:47 PM EST - Market open
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $4.57 million as of January 6, 2026. Its market cap has increased by 23.45% in one year.
Market Cap
4.57M
Enterprise Value
-4.19M
1-Year Change
23.45%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $4.57M, a decrease of -82.43%. That is a compound annual growth rate of -28.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 3.10M | 3.33% |
| Dec 31, 2025 | 3.00M | -11.76% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
| Nov 16, 2020 | 26.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |